Appointment booking for Dr. Charles Kaupke, MD is currently not available.Dr. Charles Kaupke, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Charles Kaupke, MD (he/him) is a Nephrologist in Orange, CA with over 18 years of experience. What is your opinion of Dr. Charles Kaupke, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Charles Kaupke, MD has received over $4,056 which includes payments from the following companies:
$1,964.88 from AstraZeneca AB
$1,193.83 from Celgene Corporation
$138.22 from Amgen Inc.
$134.73 from Astute Medical, Inc.
$110.74 from Otsuka America Pharmaceutical, Inc.
$107.76 from Keryx Biopharmaceuticals, Inc.
$61.28 from Questcor Pharmaceuticals
$44.88 from Veloxis Pharmaceuticals, Inc.
$43.90 from Arbor Pharmaceuticals, Inc.
$40.19 from OPKO Pharmaceuticals, LLC
$40.03 from Astellas Pharma US Inc
$39.17 from Fresenius USA Marketing, Inc.
$24.35 from AstraZeneca Pharmaceuticals LP
$23.91 from Lundbeck LLC
$19.99 from Sanofi Pasteur Inc.
$18.90 from Relypsa, Inc.
$18.71 from sanofi-aventis U.S. LLC
$16.10 from E.R. Squibb & Sons, L.L.C.
$15.35 from Daiichi Sankyo Inc.
Payments received by Dr. Charles Kaupke, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!